Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes
Diabetes Care · 2023
DOI: 10.2337/dc23-0855 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, 2023. Verfasst von Altayeb Ahmed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Inflammation Research and Translational Medicine, Department of Life Sciences, Brunel University London, London, U.K. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: British Heart Foundation, Diabetes UK.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE To investigate the causal association of type 2 diabetes and its components with risk of vascular complications independent of shared risk factors obesity and hypertension and to identify the main driver of this risk. RESEARCH DESIGN AND METHODS We conducted Mendelian randomization (MR) using independent genetic variants previously associated with type 2 diabetes, fasting glucose, HbA1c, fasting insulin, BMI, and systolic blood pressure as instrumental variables. We obtained summary-level data for 18 vascular diseases (15 for type 2 diabetes) from FinnGen and publicly available genome-wide association studies as our outcomes. We conducted univariable and multivariable MR, in addition to sensitivity tests to detect and minimize pleiotropic effects. RESULTS Univariable MR analysis showed that type 2 diabetes was associated with 9 of 15 outcomes; BMI and systolic blood pressure were associated with 13 and 15 of 18 vascular outcomes, respectively; and fasting insulin was associated with 4 and fasting glucose with 2. No robust association was found for HbA1c instruments. With adjustment for correlated traits in the multivariable test, BMI and systolic blood pressure, consistent causal effects were maintained, while five associations with type 2 diabetes (chronic kidney disease, ischemic heart disease, heart failure, subarachnoid hemorrhage, and intracerebral hemorrhage) were attenuated to null. CONCLUSIONS Our findings add strong evidence to support the importance of BMI and systolic blood pressure in the development of vascular complications in people with type 2 diabetes. Such findings strongly support the need for better weight and blood pressure management in type 2 diabetes, independent of glucose lowering, to limit important complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Inflammation Research and Translational Medicine, Department of Life Sciences, Brunel University London, London, U.K.
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, U.K.
- College of Health and Science, University of Lincoln, Lincoln, Lincolnshire, U.K.
ORCID-Profile: Altayeb Ahmed, Naveed Sattar
Förderung
- British Heart Foundation
- Diabetes UK
Zitieren
APA
Ahmed, A., Amin, H., Drenos, F., Sattar, N., & Yaghootkar, H. (2023). Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/dc23-0855
Vancouver
Ahmed A, Amin H, Drenos F, Sattar N, Yaghootkar H. Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes. Diabetes Care. 2023. doi:10.2337/dc23-0855
BibTeX
@article{Ahmed2023,
author = {Ahmed, Altayeb and Amin, Hasnat and Drenos, Fotios and Sattar, Naveed and Yaghootkar, Hanieh},
title = {Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes},
journal = {Diabetes Care},
year = {2023},
doi = {10.2337/dc23-0855}
}
EUVIMED